PTHS earnings: a negative outcome, -6.7%

On April 16, 2024, Pelthos Therapeutics Inc. reached its earnings. The result was a negative outcome, and the stock moved -6.7% in the window around the event. It had already run -39.6% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.